SCHEMBL6583311

SCHEMBL6583311

NNC(=O)c1cccc(CN2CCCC2)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.68
CYP2C9 P11712 1/20 0.68
HIF1A Q16665 1/20 0.68
PRMT6 Q96LA8 1/20 0.55
RAB9A P51151 3/20 0.54
GAA P10253 2/20 0.54
HTT P42858 2/20 0.54
HDAC1 Q13547 2/20 0.53
PTPN2 P17706 1/20 0.52
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
SMN1; SMN2 Q16637 4/20 0.50
KDM4E B2RXH2 3/20 0.50
NPC1 O15118 2/20 0.50
ALDH1A1 P00352 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
LMNA P02545 1/20 0.50
MAPK1 P28482 1/20 0.50
MAPT P10636 1/20 0.50
BDKRB1 P46663 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31721218 0.87 CHRM3 (0.61) CYP2D6CYP2C9HIF1AHDAC1HDAC8
SCHEMBL6583930 0.87 ABL1 (0.60) CYP2D6CYP2C9HIF1ARAB9AHTT
SCHEMBL1370757 0.84 CYP2D6 (0.72) CYP2D6CYP2C9HIF1APRMT6PTPN2
SCHEMBL30577950 0.84 CYP2D6 (0.72) CYP2D6CYP2C9HIF1APRMT6PTPN2
SCHEMBL1397213 0.83 CYP2D6 (0.75) CYP2D6CYP2C9HIF1APRMT6GAA
SCHEMBL27789265 0.83 CYP2D6 (0.79) CYP2D6CYP2C9HIF1APRMT6GAA
SCHEMBL29631127 0.83 CYP2D6 (0.97) CYP2D6CYP2C9HIF1APRMT6GAA
SCHEMBL11369241 0.83 CYP2D6 (0.97) CYP2D6CYP2C9HIF1APRMT6GAA
SCHEMBL1370756 0.81 CYP2D6 (0.72) CYP2D6CYP2C9HIF1APRMT6GAA
Hydrochloric Acid SCHEMBL1371448 0.81 CYP2D6 (0.94) CYP2D6CYP2C9HIF1APRMT6GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070708-B1 Triazole derivatives HOFFMANN LA ROCHE (CH) 2004-01-14 EP disclosed
US-6265426-B1 CENTRAL NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. 2001-07-24 US disclosed
EP-1070708-A1 Triazole and imidazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2001-01-24 EP disclosed